Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression

被引:107
作者
Kim, SH [1 ]
Kim, J [1 ]
Sharma, RP [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Interdisciplinary Program Toxicol, Athens, GA 30602 USA
关键词
p38; ERK; nitric oxide; iNOS; tumor necrosis factor-alpha; cytokines; LPS; ROS;
D O I
10.1016/j.phrs.2003.11.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mitogen-activated protein kinases (MAPKs) are thought to have a critical role in lipopolysaccharide (LPS)-induced immune responses but the molecular mechanisms underlying the mediation of these signaling are not clear. The roles of p38 and extracellular signal-regulated kinase (ERK) in the regulation of nitric oxide (NO) and proinflammatory cytokine expression in J774A.1 macrophages in response to LPS were examined. Specific inhibitors for p38 and ERK, SB203580 and PD98059, respectively, were used. LPS (30 ng/ml) activated inducible nitric oxide synthase (iNOS), subsequent NO production, and gene expression for tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, IL-6 and IL-12. Treatment of cultures with SB203580 increased LPS-induced reactive oxygen species (ROS) production, whereas both SB203580 and PD98059 decreased LPS-induced NO production. Concomitant decreases in the expression of iNOS mRNA and protein were detected. SB203580 and PD98059 decreased LPS-induced gene expression of IL-1beta and IL-6. SB203580 increased LPS-induced expression of TNF-alpha and IL-12; PD98059 had no effect on these cytokines. Results indicated that both p38 and ERK pathways are involved in LPS-stimulated NO synthesis and the expression of IL-1beta and IL-6. p38 signaling pathway is involved in LPS-induced ROS, TNF-alpha and IL-12 production. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 31 条
[1]   Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ [J].
Ajizian, SJ ;
English, BK ;
Meals, EA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :939-944
[2]  
Baldassare JJ, 1999, J IMMUNOL, V162, P5367
[3]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[4]   Regulation of tumour necrosis factor α mRNA stability by the mitogen-activated protein kinase p38 signalling cascade [J].
Brook, M ;
Sully, G ;
Clark, AR ;
Saklatvala, J .
FEBS LETTERS, 2000, 483 (01) :57-61
[5]   Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1β in RAW264 macrophages [J].
Caivano, M ;
Cohen, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3018-3025
[6]   IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line [J].
Chan, ED ;
Riches, DWH .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (03) :C441-C450
[7]   Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin [J].
Chandel, NS ;
Trzyna, WC ;
McClintock, DS ;
Schumacker, PT .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :1013-1021
[8]  
Chen CC, 1999, MOL PHARMACOL, V55, P481
[9]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689
[10]  
Feng GJ, 1999, J IMMUNOL, V163, P6403